• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gba2 对神经病变型戈谢病和α-突触核蛋白在斑马鱼(Oryzias latipes)中积累的影响。

Impact of Gba2 on neuronopathic Gaucher's disease and α-synuclein accumulation in medaka (Oryzias latipes).

机构信息

Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan.

Department of Pathology and Laboratory Medicine, Institute On Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, 19104-2676, USA.

出版信息

Mol Brain. 2021 May 10;14(1):80. doi: 10.1186/s13041-021-00790-x.

DOI:10.1186/s13041-021-00790-x
PMID:33971917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8111776/
Abstract

Homozygous mutations in the lysosomal glucocerebrosidase gene, GBA1, cause Gaucher's disease (GD), while heterozygous mutations in GBA1 are a strong risk factor for Parkinson's disease (PD), whose pathological hallmark is intraneuronal α-synuclein (asyn) aggregates. We previously reported that gba1 knockout (KO) medaka exhibited glucosylceramide accumulation and neuronopathic GD phenotypes, including short lifespan, the dopaminergic and noradrenergic neuronal cell loss, microglial activation, and swimming abnormality, with asyn accumulation in the brains. A recent study reported that deletion of GBA2, non-lysosomal glucocerebrosidase, in a non-neuronopathic GD mouse model rescued its phenotypes. In the present study, we generated gba2 KO medaka and examined the effect of Gba2 deletion on the phenotypes of gba1 KO medaka. The Gba2 deletion in gba1 KO medaka resulted in the exacerbation of glucosylceramide accumulation and no improvement in neuronopathic GD pathological changes, asyn accumulation, or swimming abnormalities. Meanwhile, though gba2 KO medaka did not show any apparent phenotypes, biochemical analysis revealed asyn accumulation in the brains. gba2 KO medaka showed a trend towards an increase in sphingolipids in the brains, which is one of the possible causes of asyn accumulation. In conclusion, this study demonstrated that the deletion of Gba2 does not rescue the pathological changes or behavioral abnormalities of gba1 KO medaka, and GBA2 represents a novel factor affecting asyn accumulation in the brains.

摘要

溶酶体葡萄糖脑苷脂酶基因 GBA1 的纯合突变导致戈谢病(GD),而 GBA1 的杂合突变是帕金森病(PD)的一个强烈危险因素,其病理特征是神经元内α-突触核蛋白(asyn)聚集。我们之前报道过 gba1 敲除(KO)斑马鱼表现出葡萄糖脑苷脂积累和神经病变 GD 表型,包括寿命缩短、多巴胺能和去甲肾上腺素能神经元细胞丢失、小胶质细胞激活和游泳异常,同时大脑中 asyn 积累。最近的一项研究报道,非溶酶体葡萄糖脑苷脂酶 GBA2 的缺失在非神经病变 GD 小鼠模型中挽救了其表型。在本研究中,我们生成了 gba2 KO 斑马鱼,并研究了 Gba2 缺失对 gba1 KO 斑马鱼表型的影响。gba1 KO 斑马鱼中 Gba2 的缺失导致葡萄糖脑苷脂积累加剧,而对神经病变 GD 病理变化、asyn 积累或游泳异常没有改善。同时,尽管 gba2 KO 斑马鱼没有表现出任何明显的表型,但生化分析显示大脑中 asyn 积累。gba2 KO 斑马鱼大脑中的神经鞘脂略有增加,这可能是 asyn 积累的原因之一。总之,本研究表明 Gba2 的缺失不能挽救 gba1 KO 斑马鱼的病理变化或行为异常,GBA2 是影响大脑中 asyn 积累的一个新因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/fdd98a08c726/13041_2021_790_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/bc4bcf199397/13041_2021_790_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/1920d0be9b43/13041_2021_790_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/415f5ed47d42/13041_2021_790_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/633a6958514f/13041_2021_790_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/5a7e2498b2d8/13041_2021_790_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/fdd98a08c726/13041_2021_790_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/bc4bcf199397/13041_2021_790_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/1920d0be9b43/13041_2021_790_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/415f5ed47d42/13041_2021_790_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/633a6958514f/13041_2021_790_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/5a7e2498b2d8/13041_2021_790_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3748/8111776/fdd98a08c726/13041_2021_790_Fig6_HTML.jpg

相似文献

1
Impact of Gba2 on neuronopathic Gaucher's disease and α-synuclein accumulation in medaka (Oryzias latipes).Gba2 对神经病变型戈谢病和α-突触核蛋白在斑马鱼(Oryzias latipes)中积累的影响。
Mol Brain. 2021 May 10;14(1):80. doi: 10.1186/s13041-021-00790-x.
2
Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein.青鳉(Oryzias latipes)中可行的神经元型戈谢病模型显示α-突触核蛋白在轴突中积累。
PLoS Genet. 2015 Apr 2;11(4):e1005065. doi: 10.1371/journal.pgen.1005065. eCollection 2015 Apr.
3
Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death.1型葡萄糖脑苷脂酶缺乏的斑马鱼反映了人类戈谢病的关键病理特征,并为α-突触核蛋白非依赖性神经元细胞死亡之前的早期小胶质细胞激活提供了证据。
Hum Mol Genet. 2015 Dec 1;24(23):6640-52. doi: 10.1093/hmg/ddv369. Epub 2015 Sep 16.
4
A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin.一种神经元型戈谢病的果蝇模型显示溶酶体自噬缺陷、mTOR信号改变,且雷帕霉素可对其进行功能挽救。
J Neurosci. 2016 Nov 16;36(46):11654-11670. doi: 10.1523/JNEUROSCI.4527-15.2016.
5
Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease.酸性鞘磷脂酶参与导致 GBA1 相关帕金森病 iPSC 模型中α-突触核蛋白积累的致病级联反应。
Hum Mol Genet. 2023 May 18;32(11):1888-1900. doi: 10.1093/hmg/ddad025.
6
Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.溶酶体运输缺陷将帕金森病与戈谢病联系起来。
Mov Disord. 2016 Nov;31(11):1610-1618. doi: 10.1002/mds.26802. Epub 2016 Sep 13.
7
Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.多巴胺能神经元中的葡萄糖脑苷脂酶缺乏会诱导小胶质细胞活化而不发生神经退行性变。
Hum Mol Genet. 2017 Jul 15;26(14):2603-2615. doi: 10.1093/hmg/ddx120.
8
Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes.GBA1 缺陷型小鼠脑和戈谢白细胞中葡萄糖脑苷脂酶(GBA)2 活性增加。
J Inherit Metab Dis. 2013 Sep;36(5):869-72. doi: 10.1007/s10545-012-9561-3. Epub 2012 Nov 15.
9
D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.D409H GBA1 突变加速 A53T α-突触核蛋白转基因小鼠模型的病理学进展。
Acta Neuropathol Commun. 2018 Apr 27;6(1):32. doi: 10.1186/s40478-018-0538-9.
10
Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.非溶酶体神经酰胺酶 2 的功能和遗传特征作为戈谢病的修饰因子。
Orphanet J Rare Dis. 2013 Sep 26;8:151. doi: 10.1186/1750-1172-8-151.

引用本文的文献

1
Application of CRISPR/Cas9 technology in the modeling of Gaucher disorder.CRISPR/Cas9技术在戈谢病建模中的应用。
Biochem Biophys Rep. 2024 Nov 19;40:101872. doi: 10.1016/j.bbrep.2024.101872. eCollection 2024 Dec.
2
A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy.一种基于脂质纳米颗粒的少突胶质细胞特异性mRNA疗法。
Mol Ther Nucleic Acids. 2024 Nov 5;35(4):102380. doi: 10.1016/j.omtn.2024.102380. eCollection 2024 Dec 10.
3
Animal Models for the Study of Gaucher Disease.用于戈谢病研究的动物模型。

本文引用的文献

1
Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol.葡萄糖脑苷脂酶催化一个反式半乳糖基化反应,生成一种新鉴定的脑固醇代谢物,半乳糖化胆固醇。
J Biol Chem. 2020 Apr 17;295(16):5257-5277. doi: 10.1074/jbc.RA119.012502. Epub 2020 Mar 6.
2
GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease.GBA 杂合子不足通过改变帕金森病前驱模型中的脂质代谢加速α-突触核蛋白病理。
Hum Mol Genet. 2019 Jun 1;28(11):1894-1904. doi: 10.1093/hmg/ddz030.
3
Species-specific differences in nonlysosomal glucosylceramidase GBA2 function underlie locomotor dysfunction arising from loss-of-function mutations.
Int J Mol Sci. 2023 Nov 7;24(22):16035. doi: 10.3390/ijms242216035.
4
Distinct sets of lysosomal genes define synucleinopathy and tauopathy.不同的溶酶体基因集定义了突触核蛋白病和tau 病。
BMB Rep. 2023 Dec;56(12):657-662. doi: 10.5483/BMBRep.2023-0109.
5
Teleost Fish and Organoids: Alternative Windows Into the Development of Healthy and Diseased Brains.硬骨鱼与类器官:洞察健康与患病大脑发育的新窗口
Front Mol Neurosci. 2022 Aug 11;15:855786. doi: 10.3389/fnmol.2022.855786. eCollection 2022.
特定物种中非溶酶体神经酰胺酶 GBA2 功能的差异是由功能丧失突变引起的运动功能障碍的基础。
J Biol Chem. 2019 Mar 15;294(11):3853-3871. doi: 10.1074/jbc.RA118.006311. Epub 2019 Jan 20.
4
α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies.α-突触核蛋白与神经肌醇直接但可逆地相互作用:对 α-突触核蛋白病的影响。
Sci Rep. 2018 Aug 20;8(1):12462. doi: 10.1038/s41598-018-30808-9.
5
Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain.甘神经鞘脂水平和葡萄糖脑苷脂酶活性在小鼠大脑的正常衰老中发生改变。
Neurobiol Aging. 2018 Jul;67:189-200. doi: 10.1016/j.neurobiolaging.2018.02.028. Epub 2018 Mar 29.
6
GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers.GBA1 缺乏会对生理 α-突触核蛋白四聚体及相关多聚体产生负面影响。
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):798-803. doi: 10.1073/pnas.1700465115. Epub 2018 Jan 8.
7
Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide.葡萄糖神经酰胺导致 α-突触核蛋白发生可逆构象转换,形成毒性聚集体。
Neuron. 2018 Jan 3;97(1):92-107.e10. doi: 10.1016/j.neuron.2017.12.012. Epub 2017 Dec 28.
8
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.葡糖神经鞘氨醇在突变型GBA相关帕金森病中促进α-突触核蛋白病变。
J Neurosci. 2017 Oct 4;37(40):9617-9631. doi: 10.1523/JNEUROSCI.1525-17.2017. Epub 2017 Aug 28.
9
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models.葡糖神经酰胺合酶抑制可减轻突触核蛋白病模型中的异常情况。
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2699-2704. doi: 10.1073/pnas.1616152114. Epub 2017 Feb 21.
10
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.戈谢病的病理生理学、临床表现及治疗综述
Int J Mol Sci. 2017 Feb 17;18(2):441. doi: 10.3390/ijms18020441.